2010 Focused Update of ESC Guidelines on device therapy in heart failure (Q57312500)

Claudio Ceconi

15

0 references

John McMurray

John McMurray

7

0 references

Piotr Ponikowski

Piotr Ponikowski

8

0 references

Christian Funck-Brentano

18

Christian Funck-Brentano

0 references

Gerasimos Filippatos

17

Gerasimos Filippatos

0 references

Per Anton Sirnes

25

Per Anton Sirnes

0 references

Karl Swedberg

37

Karl Swedberg

0 references

Angelo Auricchio

4

Angelo Auricchio

0 references

Zbigniew Kalarus

35

Zbigniew Kalarus

0 references

Michał Tendera

26

Michal Tendera

0 references

Michał Tendera

29

Michal Tendera

0 references

Stefan D. Anker

30

Stefan D. Anker

0 references

Jeroen Joost Bax

14

Jeroen Bax

0 references

Kenneth Dickstein

2

Kenneth Dickstein

0 references

Udo Sechtem

24

Udo Sechtem

0 references

Dirk J van Veldhuisen

11

Dirk J. van Veldhuisen

0 references

Petr Widimský

28

Petr Widimsky

0 references

Arno W. Hoes

33

Arno W. Hoes

0 references

A. John Camm

38

A. John Camm

0 references

Richard Hobbs

19

Richard Hobbs

0 references

Theresa A McDonagh

21

Theresa McDonagh

0 references

Panos N Vardas

3

Panos E. Vardas

0 references

Panos N Vardas

27

Panos Vardas

0 references

Jean-Claude Daubert

5

Jean-Claude Daubert

0 references

Angelo Auricchio

13

Angelo Auricchio

0 references

Maurizio Gasparini

32

Maurizio Gasparini

0 references

Carsten W. Israel

34

Carsten W. Israel

0 references

Alec Vahanian

12

Alec Vahanian

0 references

author name string

Silvia Giuliana Priori

9

0 references

Richard Sutton

10

0 references

Veronica Dean

16

0 references

Peter Kearney

20

0 references

Bogdan A. Popescu

22

0 references

Zeljko Reiner

23

0 references

Jean-Jacques Blanc

31

0 references

Bela Merkely

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

36

0 references

publication date

1 November 2010

0 references

published in

EP Europace

0 references

volume

12

0 references

page(s)

1526-1536

0 references

issue

11

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

The current cost of heart failure to the National Health Service in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

The effect of cardiac resynchronization on morbidity and mortality in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac-resynchronization therapy for the prevention of heart-failure events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

The European cardiac resynchronization therapy survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Biventricular pacing in patients with bradycardia and normal ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Advanced heart failure treated with continuous-flow left ventricular assist device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Pacing Therapies in Congestive Heart Failure II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392

Long-Term Effects of Upgrading to Biventricular Pacing: Differences with Cardiac Resynchronization Therapy as Primary Indication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUQ392